,,,humm,,,,from what I have read BP are more inclined to come aboard after successful completion of trials. They certainly partner and do other deal arrangements which is still possible. In fact it was written that it can be years after the sales of the drug before they shell out for ownership. So we are a long ways off from that point in the business.

If this is true where does that leave DM and gang to meet our end points. RVX definitly want a juicy price to sell out 208 and or the whole of the epigenetics program. Will BP accept that risk??,,,maybe they are willing to pay a bigger price for the reduction in risk. To that end it leaves us with the beg and borrow deals we may continue to see going forward. Hepa had to protect their investment by making this latest deal. Eastern will now protect their investment by doing this next financing, and sharing the risk going forward with us minions.

KD is not walking away from a possible block buster,,didnt DM say Eastern noted earlier they were willing to take 208 to the counter!!!!!,,,KD has no issue with taking on risk!,,just look at his history in the world of big business where risk has been even higher. He does know there is no money in flogging a dead horse and he showed us he will lock the doors at any venture that does not fullfill that criteria. So in my mind,,we will defintily see him back at the trough here,,,,,the future financing for RVX has possibly always been under a hand shake and a verbal commitment to the big insiders. And if that is reasonable to assume then the levels where they buy in is also agreed on,,,,maybe thats part of the trading pattern we see where the weak level in share price seems to track us like toilet paper stuck to your shoe!!!..........We will see shortly,,,,,,,,,,,,,,,,,,,,,,,jmo